Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

NCT07210619 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

oGVHD

Interventions

DRUG: d-MAPPS

Sponsor

Regenerative Ocular Immunobiologics LLC